HEATHER RICHARDSON: Open Payments
NPI 1851052427 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 109 payments from 23 companies in 2025. Trend: 2023 $1,088 · 2024 $1,555 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $249 |
| Novo Nordisk Inc | 11 | $204 |
| AstraZeneca Pharmaceuticals LP | 11 | $189 |
| Otsuka America Pharmaceutical, Inc. | 10 | $138 |
| Lilly USA, LLC | 10 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Abbott Laboratories | 3 | $71 |
| Verona Pharma, Inc. | 4 | $58 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
Products named: REXULTI, Ozempic, VRAYLAR, BREZTRI, MOUNJARO, CAPLYTA, FREESTYLE LIBRE, Ohtuvayre.
Industry payments across MO — which companies pay providers there.
